Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2016

Ausgabe 3/2016

Inhaltsverzeichnis ( 27 Artikel )

01.02.2016 | Editorial | Ausgabe 3/2016

Note of clarification regarding data about the association between the interleukin-1β −31T>C polymorphism and breast cancer risk

Yadong Wang, Yan Wang, Li Li

01.02.2016 | Editorial | Ausgabe 3/2016

Note of clarification regarding data on the association between the interleukin-1β −511C>T polymorphism and breast cancer risk

Yadong Wang, Xinwei Chu, Haiyu Wang

01.02.2016 | Preclinical study | Ausgabe 3/2016 Open Access

Natural history of age-related lobular involution and impact on breast cancer risk

Derek C. Radisky, Daniel W. Visscher, Ryan D. Frank, Robert A. Vierkant, Stacey Winham, Melody Stallings-Mann, Tanya L. Hoskin, Aziza Nassar, Celine M. Vachon, Lori A. Denison, Lynn C. Hartmann, Marlene H. Frost, Amy C. Degnim

01.02.2016 | Preclinical study | Ausgabe 3/2016

Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin

Marcia R. Campbell, Hui Zhang, Shabnam Ziaee, Ana Ruiz-Saenz, Nathaniel Gulizia, Julie Oeffinger, Dhara N. Amin, Deepika Ahuja, Mark M. Moasser, Catherine C. Park

01.02.2016 | Preclinical study | Ausgabe 3/2016

High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation

Xiaoqin Huang, Dan He, Jia Ming, Yubin He, Champion Zhou, Hui Ren, Xin He, Chenguang Wang, Jingru Jin, Liang Ji, Belinda Willard, Bing Pan, Lemin Zheng

01.02.2016 | Preclinical study | Ausgabe 3/2016

HER2 FISH classification of equivocal HER2 IHC breast cancers with use of the 2013 ASCO/CAP practice guideline

Yao-Shan Fan, Carmen E. Casas, Jinghong Peng, Melanie Watkins, Lynn Fan, Jennifer Chapman, Offiong Francis Ikpatt, Carmen Gomez, Wei Zhao, Isildinha M. Reis

01.02.2016 | Clinical trial | Ausgabe 3/2016 Open Access

Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer

Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance
Giuseppe Viale, Leen Slaets, Femke A. de Snoo, Jan Bogaerts, Leila Russo, Laura van’t Veer, Emiel J. T. Rutgers, Martine J. Piccart-Gebhart, Lisette Stork-Sloots, Patrizia Dell’Orto, Annuska M. Glas, Fatima Cardoso

01.02.2016 | Clinical trial | Ausgabe 3/2016

The effect of resistance training on markers of immune function and inflammation in previously sedentary women recovering from breast cancer: a randomized controlled trial

Amanda D. Hagstrom, Paul W. M. Marshall, Chris Lonsdale, Shona Papalia, Birinder S. Cheema, Catherine Toben, Bernhard T. Baune, Maria A. Fiatarone Singh, Simon Green

01.02.2016 | Clinical trial | Ausgabe 3/2016

Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor

Brandon S. Sheffield, Zuzana Kos, Karama Asleh-Aburaya, Xiu Qing Wang, Samuel Leung, Dongxia Gao, Jennifer Won, Christine Chow, Rakesh Rachamadugu, Inge Stijleman, Robert Wolber, C. Blake Gilks, Nickolas Myles, Tom Thomson, Malcolm M. Hayes, Philip S. Bernard, Torsten O. Nielsen, Stephen K. L. Chia

01.02.2016 | Clinical trial | Ausgabe 3/2016

Effect of a randomized controlled exercise trial on bone outcomes: influence of adjuvant endocrine therapy

M. Tish Knobf, Sangchoon Jeon, Barbara Smith, Lyndsay Harris, Jane Kerstetter, A. Siobhan Thompson, Karl Insogna

01.02.2016 | Clinical Trial | Ausgabe 3/2016

Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS)

Alice C. Shapiro, Susan A. Adlis, Kim Robien, Mark N. Kirstein, Shuang Liang, Sara A. Richter, Rachel E. Lerner

01.02.2016 | Clinical trial | Ausgabe 3/2016

Comparison of intra-operative specimen mammography to standard specimen mammography for excision of non-palpable breast lesions: a randomized trial

Cynthia L. Miller, Suzanne B. Coopey, Elizabeth Rafferty, Michele Gadd, Barbara L. Smith, Michelle C. Specht

01.02.2016 | Clinical trial | Ausgabe 3/2016

A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies

Amy Jo Chien, Alyson Cockerill, Craig Fancourt, Emmett Schmidt, Mark M. Moasser, Hope S. Rugo, Michelle E. Melisko, Andrew H. Ko, R. Katie Kelley, W. Michael Korn, Laura J. Esserman, Laura van‘t Veer, Christina Yau, Denise M. Wolf, Pamela N. Munster

01.02.2016 | Epidemiology | Ausgabe 3/2016

Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium

Mia M. Gaudet, Myrto Barrdahl, Sara Lindström, Ruth C. Travis, Paul L. Auer, Julie E. Buring, Stephen J. Chanock, A. Heather Eliassen, Susan M. Gapstur, Graham G. Giles, Marc Gunter, Christopher Haiman, David J. Hunter, Amit D. Joshi, Rudolf Kaaks, Kay-Tee Khaw, I-Min Lee, Loic Le Marchand, Roger L. Milne, Petra H. M. Peeters, Malin Sund, Rulla Tamimi, Antonia Trichopoulou, Elisabete Weiderpass, Xiaohong R. Yang, Ross L. Prentice, Heather Spencer Feigelson, Federico Canzian, Peter Kraft

01.02.2016 | Epidemiology | Ausgabe 3/2016

Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community

Michael J. Hassett, Wei Jiang, Laurel A. Habel, Larissa Nekhlyudov, Ninah Achacoso, Luana Acton, Stuart J. Schnitt, Deb Schrag, Rinaa S. Punglia

01.02.2016 | Epidemiology | Ausgabe 3/2016

Impact of very low physical activity, BMI, and comorbidities on mortality among breast cancer survivors

Sandahl H. Nelson, Catherine R. Marinac, Ruth E. Patterson, Sarah J. Nechuta, Shirley W. Flatt, Bette J. Caan, Marilyn L. Kwan, Elizabeth M. Poole, Wendy Y. Chen, Xiao-ou Shu, John P. Pierce

01.02.2016 | Epidemiology | Ausgabe 3/2016

Associations of sex steroid hormones with mortality in women with breast cancer

Catherine Duggan, Frank Stanczyk, Kristin Campbell, Marian L. Neuhouser, Richard N. Baumgartner, Kathy B. Baumgartner, Leslie Bernstein, Rachel Ballard, Anne McTiernan

01.02.2016 | Epidemiology | Ausgabe 3/2016

Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers

Ines Vaz-Luis, Melissa E. Hughes, Angel Cronin, Hope S. Rugo, Stephen B. Edge, Beverly Moy, Richard L. Theriault, Michael J. Hassett, Eric P. Winer, Nancy U. Lin

01.02.2016 | Epidemiology | Ausgabe 3/2016

Healthy dietary patterns and risk of breast cancer by molecular subtype

Kelly A. Hirko, Walter C. Willett, Susan E. Hankinson, Bernard A. Rosner, Andrew H. Beck, Rulla M. Tamimi, A. Heather Eliassen

01.02.2016 | Epidemiology | Ausgabe 3/2016

Clinical predictors of long-term survival in HER2-positive metastatic breast cancer

Pooja Murthy, Kelley M. Kidwell, Anne F. Schott, Sofia D. Merajver, Jennifer J. Griggs, Jeffrey D. Smerage, Catherine H. Van Poznak, Max S. Wicha, Daniel F. Hayes, N. Lynn Henry

01.02.2016 | Epidemiology | Ausgabe 3/2016

Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens

D. G. Evans, F. Lalloo, S. Howell, S. Verhoef, E. R. Woodward, A. Howell

01.02.2016 | Brief Report | Ausgabe 3/2016

Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigm

Lynn Jongen, Robert Paridaens, Giuseppe Floris, Hans Wildiers, Patrick Neven

01.02.2016 | Erratum | Ausgabe 3/2016

Erratum to: Recombinant viral protein VP1 suppresses HER-2 expression and migration/metastasis of breast cancer

Shao-Wen Hung, Ching-Feng Chiu, Tai-An Chen, Chiao-Li Chu, Chi-Chang Huang, Lie-Fen Shyur, Chi-Ming Liang, Shu-Mei Liang

01.02.2016 | Erratum | Ausgabe 3/2016

Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option

Ziyan Yuan Pessetto, Ying Yan, Tadayoshi Bessho, Amarnath Natarajan

01.02.2016 | Erratum | Ausgabe 3/2016

Erratum to: CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis

Subir Biswas, Suman Sengupta, Sougata Roy Chowdhury, Samir Jana, Gunjan Mandal, Palash Kumar Mandal, Nipun Saha, Vivek Malhotra, Arnab Gupta, Dmitry V. Kuprash, Arindam Bhattacharyya

01.02.2016 | Erratum | Ausgabe 3/2016

Erratum to: Vaccination with ErbB-2 peptides prevents cancer stem cell expansion and suppresses the development of spontaneous tumors in MMTV-PyMT transgenic mice

Eun-Young Gil, Uk-Hyun Jo, Hye Jin Lee, Jinho Kang, Jae Hong Seo, Eun Sook Lee, Yeul Hong Kim, InSun Kim, Vy Phan-Lai, Mary L. Disis, Kyong Hwa Park

01.02.2016 | Erratum | Ausgabe 3/2016

Erratum to: A nomogram based on mammary ductoscopic indicators for evaluating the risk of breast cancer in intraductal neoplasms with nipple discharge

Zhen-Qiang Lian, Qi Wang, An-Qin Zhang, Jiang-Yu Zhang, Xiao-Rong Han, Hai-Yun Yu, Si-Mei Xie

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise